SilverCloud as a School-Based Intervention for Vulnerable Youth
Hybrid Type I Effectiveness-implementation Trial of SilverCloud as a School-based Intervention for Vulnerable Youth
1 other identifier
interventional
120
1 country
3
Brief Summary
The goal of this study is to test the efficacy and feasibility of a clinician-guided, app-based cognitive behavioral therapy (CBT) program, SilverCloud, as a school-based mental health intervention for vulnerable youth. An open trial of SilverCloud will be conducted to determine preliminary efficacy in this sample and inform program refinements by collecting outcome self-report assessments and conducting interviews on feasibility and acceptability. After the program and its implementation strategy are refined, we will conduct an randomized controlled trial. Adolescents who seek or are referred for mental health services through one of the study sites and screen positive for significant mental health symptoms will be randomized to receive SilverCloud or treatment as usual (TAU). Efficacy will be assessed through outcome self-reports. Feasibility and acceptability feedback will again be collected from participants, SBHC staff, and community members.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Feb 2024
Typical duration for not_applicable depression
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2023
CompletedFirst Posted
Study publicly available on registry
August 22, 2023
CompletedStudy Start
First participant enrolled
February 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
March 30, 2026
March 1, 2026
2.9 years
August 17, 2023
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Patient Health Questionnaire-9 (PHQ-9) Score
The PHQ-9 is a 9-item questionnaire assessing the degree of depression severity. Items are ranked on a 4-point scale ranging from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0-27; higher scores indicate greater severity of depression.
Baseline, Week 8
Change in General Anxiety Disorder-7 (GAD-7) Score
The GAD-7 is a 7-item questionnaire assessing the degree of anxiety severity. Items are ranked on a 4-point scale ranging from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0-21; higher scores indicate greater severity of anxiety.
Baseline, Week 8
Secondary Outcomes (5)
Change in Revised Children's Anxiety and Depression Scale (RCADS-25) Youth Self-Report Score
Baseline, Week 8
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Item Bank v2.0 - Peer Relationships - Short Form 8a Score
Baseline, Week 8
Change in PROMIS Pediatric Item Bank v1.0 - Family Relationships - Short Form 8a
Baseline, Week 8
Change in PROMIS Pediatric Item Bank v1.0 - Sleep Disturbance - Short Form 8a
Baseline, Week 8
Change in School Engagement Scale Score
Baseline, Week 8
Study Arms (2)
SilverCloud
EXPERIMENTALAdolescents who seek or are referred for mental health services and screen positive for significant mental health symptoms randomized to receive SilverCloud.
Treatment as Usual (TAU)
ACTIVE COMPARATORAdolescents who seek or are referred for mental health services and screen positive for significant mental health symptoms randomized to receive psychotherapy.
Interventions
SilverCloud is organized into eight core modules that follow evidence-based principles of CBT, along with six additional modules that can be prescribed by the clinician to address a participant's specific needs.
Psychotherapy with a licensed clinician at one of the study sites.
Eligibility Criteria
You may qualify if:
- In order to be eligible to participate in the phase I open trial of this study, an individual must meet all of the following criteria:
- Enrolled in a high school
- Score of 10+ on GAD-7 or PHQ-9
- Speak/read English. The current investigational version of SilverCloud that will be used in this study is only available in English.
- In order to be eligible to participate in the RCT of this study, an individual must meet all of the following criteria:
- Enrolled in 9th through 11th grades.
- Score of 10+ on GAD-7 or PHQ-9
- Enrolled in one of the study sites
- Speak/read English. The current investigational version of SilverCloud that will be used in this study is only available in English.
You may not qualify if:
- An individual who meets any of the following criteria will be excluded from participation in the phase I open trial of this study:
- Does not use a smartphone
- Mental health concerns for which intensive treatment is indicated. Because SilverCloud has not been evaluated in people with serious mental illness, participants who exhibit symptoms of mania or psychosis will be referred to a higher level of care.
- Current suicidal ideation with intent. Participants who have a suicide plan and intent to act on it will be referred to the SBHC suicide risk protocol and will not be eligible until their suicidal thoughts have abated.
- An individual who meets any of the following criteria will be excluded from participation in the RCT of this study:
- Current (within 1 month of enrollment) mental health treatment at one of the study sites
- Does not use a smartphone
- Mental health concerns for which intensive treatment is indicated. Because SilverCloud has not been evaluated in people with serious mental illness, participants who exhibit symptoms of mania or psychosis will be referred to a higher level of care.
- Current suicidal ideation with intent. Participants who have a suicide plan and intent to act on it will be referred for crisis intervention through the site at which they were referred and will not be eligible until their suicidal thoughts have abated.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NYU Langone Healthlead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (3)
Rutgers University
New Brunswick, New Jersey, 08901, United States
NYU Langone Health
Brooklyn, New York, 11220, United States
Northwell Health School Mental Health Partnership sites
Glen Oaks, New York, 11004, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Van Meter, PhD
NYU Langone Health
- PRINCIPAL INVESTIGATOR
Erum Nadeem, PhD
Rutgers University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2023
First Posted
August 22, 2023
Study Start
February 8, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
June 30, 2027
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Immediately following publication. No end date.
- Access Criteria
- Investigators whose proposed use of the data has been approved by the NIMH Data Archive will be shared to achieve aims in the approved proposal. Data are available indefinitely through the NIMH Data Archive.
The de-identified participant data from the final research dataset used in the published manuscript will be shared with investigators whose proposed use of the data has been approved by the NIMH Data Archive. Data will be made available following article publication or as required by a condition of awards and agreements supporting the research. Data are available indefinitely through the NIMH Data Archive. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.